Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Practical Guidelines For Using Spironolactone In Acne Patients
Description
The session led by Emmy Graber focuses on the use of spironolactone in treating acne, acknowledging that it is not FDA-approved for this purpose and is used off-label. The forum features esteemed speakers, including Dr. Hilary Baldwin, who will explain the mechanism of action and proper patient selection; Dr. Bethany Schlosser, who will present efficacy data and potential other uses for spironolactone; and Dr. Julie Harper, who will cover contraindications and side effects. Following the presentations, there will be a panel discussion for attendees to ask questions and gain insights from different practices regarding spironolactone use. Graber emphasizes the importance of the American Acne and Rosacea Society and encourages membership. The session will also include necessary housekeeping announcements before delving into the main topics.
Conclusions
- Spironolactone is an off-label treatment for acne not FDA approved for this use.
- The mechanism of action of spironolactone in acne treatment involves anti-androgenic properties.
- Proper patient selection is essential for effective spironolactone therapy in acne.
- Efficacy data supports the use of spironolactone in certain acne patients, particularly those with hormonal imbalances.
- There are contraindications and side effects associated with spironolactone that need to be reviewed before prescribing.
- A multidisciplinary approach involving discussion among dermatologists can enhance the understanding and effectiveness of spironolactone use.